Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk

MJ Drake, S MacDiarmid, S Al-Shukri, J Barkin, A Fianu-Jonasson, S Herschorn, M Huang, M Stoelzel, E Siddiqui

Research output: Contribution to journalComment/debate (Academic Journal)peer-review

2 Citations (Scopus)
395 Downloads (Pure)

Fingerprint Dive into the research topics of 'Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk'. Together they form a unique fingerprint.

Medicine & Life Sciences